FDA Inspection 1305200 — Acme Generics Private Limited

Acme Generics Private Limited — FEI 3012112224

The FDA completed an inspection of Acme Generics Private Limited on Feb 20, 2026 in Solan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 20, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Solan (India)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.